Ckd Bio Corporation announced earnings results for the full year ended December 31, 2012. For the year, total revenue was KRW 116,232.5 million against KRW 118,151.0 million a year ago. EBIT was KRW 11,270.4 million against KRW 15,806.9 million a year ago.

Pre tax profit was KRW 8,118.6 million against KRW 12,981.7 million a year ago. Profit after tax was KRW 7,101.3 million against KRW 10,920.6 million a year ago. Return on equity was 5.7% against 9.2% a year ago.

Return on assets was 3.8% against 5.5% a year ago. EPS was KRW 1,384.0 against KRW 2,129.0 per share a year ago.